NCT07592338Completed
Agreement Between Large Language Model-Generated Treatment Recommendations With Guideline-Based and Tumor Board Decisions in Gastrointestinal Cancer
Concordance of Large Language Model-Generated Treatment Recommendations With Multidisciplinary Tumor Board and Guideline-Based Decisions in Gastrointestinal Cancer: A Retrospective Cohort Study
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
The goal of this observational study is to learn whether a computer program can suggest cancer treatments that match expert recommendations for people with gastrointestinal cancer (cancer of the pancreas, stomach, or colon and rectum). The main questions it aims to answer are: * Do the treatment suggestions from the computer program match current medical guidelines? * Do these suggestions match decisions made by a multidisciplinary tumor board (a team of cancer specialists)? Researchers will review existing medical records from people who have already been treated for these cancers. They will enter key clinical information into a computer program that uses artificial intelligence (AI). The program will generate treatment suggestions for each case. Researchers will then compare these suggestions with: * guideline-based treatment recommendations * decisions made by the tumor board This study will help researchers understand whether AI tools could support doctors in making cancer treatment decisions in the future.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 4 May 2026
- Start date
- 1 Jan 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Medizinische Hochschule Brandenburg Theodor Fontane
- NCT number
- NCT07592338
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 1 Jan 2025 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Non-adenocarcinoma histology
Who the study is looking for
- Histologically confirmed pancreatic, gastric, or colorectal adenocarcinoma
- Treatment discussed in a multidisciplinary tumor board
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Brandenburg Coordinator of this site? Confirm its status | Brandenburg an der Havel | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.